eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.90
-0.52 (-6.18%)
At close: Jun 30, 2026, 4:00 PM EDT
8.43
+0.53 (6.71%)
After-hours: Jun 30, 2026, 4:04 PM EDT
eXoZymes Employees
eXoZymes had 32 employees as of December 31, 2025. The number of employees increased by 1 or 3.23% compared to the previous year.
Employees
32
Change (1Y)
1
Growth (1Y)
3.23%
Revenue / Employee
n/a
Profits / Employee
-$302,268
Market Cap
66.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32 | 1 | 3.23% |
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| XBiotech | 87 |
| Acrivon Therapeutics | 76 |
| Seres Therapeutics | 66 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| BeyondSpring | 44 |
| Elicio Therapeutics | 33 |
| ImageneBio | 17 |
EXOZ News
- 6 days ago - eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery - Accesswire
- 13 days ago - eXoZymes Inc. Announces Closing of $6 Million Public Offering - Accesswire
- 22 days ago - eXoZymes prices 592,270 shares at $18.00 in public offering - TheFly
- 22 days ago - eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants - Accesswire
- 6 weeks ago - eXoZymes Quarterly report: Q1 2026 - Filings
- 7 weeks ago - eXoZymes announces graduation from Shell GameChanger Accelerator - TheFly
- 7 weeks ago - eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program - Accesswire
- 7 weeks ago - eXoZymes Slides: Investor presentation - Filings